JUPITER, Florida – August 15, 2023 — Ascendiant Capital Markets LLC (“Ascendiant”) announced today the filing of a $3,800,000 At-the-Market (ATM) Offering for ENDRA Life Sciences Inc. (Nasdaq: NDRA) of Ann Arbor, Michigan, pursuant to an amendment to a prospectus supplement for an ATM initially filed in 2021.
Ascendiant is serving as Sole Sales Agent on the financing transaction. For a copy of this announcement, click here.
